The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell Line
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Pan-Sirtuin Inhibitor MC2494 Regulates Mitochondrial Function in a Leukemia Cell Line
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-21
DOI
10.3389/fonc.2020.00820
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
- (2019) Vincenzo Carafa et al. Frontiers in Pharmacology
- Mitochondria in Health and Disease
- (2019) Sarah J. Annesley et al. Cells
- Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells
- (2019) Rosita Russo et al. Cancers
- Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer
- (2019) Vincenzo Carafa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses
- (2019) Francesco Napolitano et al. Scientific Reports
- RIP1–HAT1–SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer
- (2018) Vincenzo Carafa et al. CLINICAL CANCER RESEARCH
- Mitochondria in health and disease
- (2018) Sanjiban Chakrabarty et al. MITOCHONDRION
- Mitochondrial OXPHOS complex assembly lines
- (2018) Luke E. Formosa et al. NATURE CELL BIOLOGY
- Intra-mitochondrial biomineralization for inducing apoptosis of cancer cells
- (2018) Sangpil Kim et al. Chemical Science
- The roles of sirtuins family in cell metabolism during tumor development
- (2018) Shunqin Zhu et al. SEMINARS IN CANCER BIOLOGY
- Functional Mitochondria in Health and Disease
- (2017) Patries M. Herst et al. Frontiers in Endocrinology
- Mitochondria and Cancer
- (2016) Sejal Vyas et al. CELL
- p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status
- (2016) A Quintás-Cardama et al. LEUKEMIA
- The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression
- (2016) Jiandong Chen Cold Spring Harbor Perspectives in Medicine
- Sirtuin functions and modulation: from chemistry to the clinic
- (2016) Vincenzo Carafa et al. Clinical Epigenetics
- The role of mammalian sirtuins in cancer metabolism
- (2015) Carlos Sebastián et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
- (2014) Valerie S. LeBleu et al. NATURE CELL BIOLOGY
- Cancer as a metabolic disease: implications for novel therapeutics
- (2013) T. N. Seyfried et al. CARCINOGENESIS
- p53 Orchestrates the PGC-1α-Mediated Antioxidant Response Upon Mild Redox and Metabolic Imbalance
- (2012) Katia Aquilano et al. ANTIOXIDANTS & REDOX SIGNALING
- SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
- (2012) Chu-Xia Deng International Journal of Biological Sciences
- PGC1 and mitochondrial metabolism - emerging concepts and relevance in ageing and neurodegenerative disorders
- (2012) S. Austin et al. JOURNAL OF CELL SCIENCE
- Sirtuins and Disease: The Road Ahead
- (2012) Vincenzo Carafa et al. Frontiers in Pharmacology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
- (2011) Nirmalya Sen et al. MOLECULAR CELL
- Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling
- (2010) Eric Verdin et al. TRENDS IN BIOCHEMICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started